Home > Press > Arrowhead Subsidiary, Unidym, Ramps up Manufacturing to Meet Carbon Nanotube Demand
Abstract:
Unidym, Inc, a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR), announced today that it is expanding its Houston manufacturing operations to meet the growing demand for high quality carbon nanotubes used by both its transparent electrode business and the market in general. Unidym, which recently merged with Carbon Nanotechnologies, Inc. (CNI), has its headquarters in Menlo Park, California and carbon nanotube manufacturing operations in Houston, Texas.
"Unidym is ramping up to meet increasing demand for carbon nanotubes from both new and existing customers," said Art Swift, CEO and president. "Projected demand is particularly strong in electronics and composite materials applications. As a result, we are investing in additional production capacity and adding manufacturing, engineering and development personnel."
Worldwide demand for carbon nanotubes is increasing rapidly as applications for the material have matured. "The global carbon nanotubes market is expected to exceed $1.9 billion by 2010," according to a new report by Global Industry Analysts, Inc.(a), one of the many industry analysts groups that are projecting significant increases in carbon nanotube-based revenues.
Unidym's CEO Swift recently spoke at the Rice University Rice Alliance Technology Venture Forum, where the focus was on showcasing advances in nanotechnology through presentations from the leading edge researchers and companies. "We have strong Texas roots through our association with the late Dr. Richard Smalley of Rice University, the Nobel Prize winning pioneer of carbon nanotubes and founder of CNI. We expect to continue to benefit from the thriving nanotech ecosystem that exists in and around Houston."
####
About Unidym, Inc
Unidym (www.unidym.com) is a leader in the manufacture and application of carbon nanotubes (CNTs), a novel material with extraordinary electrical, thermal and mechanical properties. Unidym provides bulk materials, CNT-enabled products and intellectual property to a wide range of customers and business partners. As a result of its recent merger with CNI, Unidym possesses a foundational patent portfolio that covers nearly every aspect of CNT manufacturing and processing, as well as multiple product applications.
Unidym is focused on the electronics industry where its initial products include transparent electrodes for touch screens, flat panel displays, solar cells, and solid state lighting; electrodes for fuel cells; and thin film transistors for printable electronics. Unidym is also pursuing a cross-industry partnership strategy to capture value from the wide ranging uses of CNTs. Unidym’s licensing program, technical expertise and manufacturing facilities can enable partners to rapidly develop CNT solutions for their specific applications. Unidym is a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR) For more information about Arrowhead, please visit www.arrowheadresearch.com.
(a) Source: Carbon Nanotubes - A Global Strategic Business Report, Publisher: Global Industry Analysts, Inc. USA (www.StrategyR.com)
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K and 10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q and 10-Q/A, recent Current Reports on Forms 8-K and 8-K/A, our Registration Statement on Form S-3, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
For more information, please click here
Contacts:
Arrowhead Research Corporation
Bruce Cross
626-304-3400
Copyright © Business Wire 2008
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Openings/New facilities/Groundbreaking/Expansion
OCSiAl expands its graphene nanotube production capacities to Europe June 17th, 2022
GLOBALFOUNDRIES Moves Corporate Headquarters to its Most Advanced Semiconductor Manufacturing Facility in New York April 27th, 2021
Oxford Instruments Plasma Technology relocates to advanced manufacturing facility: Move driven by exceptional business growth February 12th, 2021
Nanotubes/Buckyballs/Fullerenes/Nanorods/Nanostrings
Tests find no free-standing nanotubes released from tire tread wear September 8th, 2023
Detection of bacteria and viruses with fluorescent nanotubes July 21st, 2023
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||